Convergent evolution of the ladder-like ventral nerve cord in Annelida C Helm, P Beckers, T Bartolomaeus, SH Drukewitz, I Kourtesis, A Weigert, ... Frontiers in zoology 15, 1-17, 2018 | 67 | 2018 |
A dipteran’s novel sucker punch: Evolution of arthropod atypical venom with a neurotoxic component in robber flies (Asilidae, Diptera) SH Drukewitz, N Fuhrmann, EAB Undheim, A Blanke, J Giribaldi, R Mary, ... Toxins 10 (1), 29, 2018 | 41 | 2018 |
The significance of comparative genomics in modern evolutionary venomics SH Drukewitz, BRM Von Reumont Frontiers in Ecology and Evolution 7, 163, 2019 | 37 | 2019 |
Toxins from scratch? Diverse, multimodal gene origins in the predatory robber fly Dasypogon diadema indicate a dynamic venom evolution in dipteran insects SH Drukewitz, L Bokelmann, EAB Undheim, BM von Reumont GigaScience 8 (7), giz081, 2019 | 27 | 2019 |
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers A Jahn, A Rump, TJ Widmann, C Heining, P Horak, B Hutter, ... Annals of Oncology 33 (11), 1186-1199, 2022 | 26 | 2022 |
Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment A Hennig, F Baenke, A Klimova, S Drukewitz, B Jahnke, S Brückmann, ... The Journal of pathology 257 (5), 607-619, 2022 | 22 | 2022 |
Comparative analyses of glycerotoxin expression unveil a novel structural organization of the bloodworm venom system S Richter, C Helm, FA Meunier, L Hering, LI Campbell, SH Drukewitz, ... BMC Evolutionary Biology 17, 1-19, 2017 | 21 | 2017 |
Decoding single cell morphology in osteotropic breast cancer cells for dissecting their migratory, molecular and biophysical heterogeneity L Bemmerlein, IA Deniz, J Karbanova, A Jacobi, S Drukewitz, T Link, ... Cancers 14 (3), 603, 2022 | 10 | 2022 |
Epigenetic drugs in somatostatin type 2 receptor radionuclide theranostics and radiation transcriptomics in mouse pheochromocytoma models M Ullrich, S Richter, J Liers, S Drukewitz, M Friedemann, J Kotzerke, ... Theranostics 13 (1), 278, 2023 | 7 | 2023 |
Combined systemic drug treatment with proton therapy: investigations on patient-derived organoids M Naumann, T Czempiel, AJ Lößner, K Pape, E Beyreuther, S Löck, ... Cancers 14 (15), 3781, 2022 | 7 | 2022 |
Treatment of pheochromocytoma cells with recurrent cycles of hypoxia: a new pseudohypoxic In vitro model J Helm, S Drukewitz, I Poser, S Richter, M Friedemann, D William, H Mohr, ... Cells 11 (3), 560, 2022 | 5 | 2022 |
Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity AA Wurm, S Brilloff, S Kolovich, S Schäfer, E Rahimian, V Kufrin, M Bill, ... Cell Reports Medicine 4 (10), 2023 | 4 | 2023 |
Breaking the ladder: Evolution of the ventral nerve cord in Annelida C Helm, P Beckers, T Bartolomaeus, SH Drukewitz, I Kourtesis, A Weigert, ... BioRxiv, 378661, 2018 | 2 | 2018 |
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold T Schmäche, J Fohgrub, A Klimova, K Laaber, S Drukewitz, F Merboth, ... Molecular Cancer 23 (1), 10, 2024 | 1 | 2024 |
Clinical Impact of Polygenic Risk Score for Breast Cancer Risk Prediction in 382 Individuals with Hereditary Breast and Ovarian Cancer Syndrome S Stiller, S Drukewitz, K Lehmann, J Hentschel, V Strehlow Cancers 15 (15), 3938, 2023 | 1 | 2023 |
Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian Cancer DM Klotz, FM Schwarz, A Dubrovska, K Schuster, M Theis, A Krüger, ... Cancers 15 (15), 3774, 2023 | 1 | 2023 |
Chronic ER stress promotes cGAS/mtDNA-induced autoimmunity via ATF6 in myotonic dystrophy type 2 C Günther, S Rösing, F Ullrich, S Meisterfeld, F Schmidt, N Eberl, ... | 1 | 2022 |
Exploring evolutionary trajectories in ovarian cancer patients by longitudinal analysis of ctDNA O Kutz, S Drukewitz, A Krüger, D Aust, D William, S Oster, E Schröck, ... Clinical Chemistry and Laboratory Medicine (CCLM), 2024 | | 2024 |
Chronic endoplasmic reticulum stress in myotonic dystrophy type 2 promotes autoimmunity via mitochondrial DNA release S Rösing, F Ullrich, S Meisterfeld, F Schmidt, L Mlitzko, M Croon, ... Nature Communications 15 (1), 1534, 2024 | | 2024 |
De novo variants in KDM2A cause a syndromic neurodevelopmental disorder-virtual K Platzer, E Anderson, S Kour, D Rajan, S Schoennagel, LM Pilgram, ... EUROPEAN JOURNAL OF HUMAN GENETICS 32, 8-9, 2024 | | 2024 |